Notably, in chronic myeloid leukemia, a unique surface expression profile has been identified in LSCs, characterized by consistent expression of markers such as CD25+, CD26+, CD56+, and IL-1RAP+ [43]. This evidence concerns the gene IL1RAP and chronic myelogenous leukemia, BCR-ABL1 positive.